Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion
- PMID: 17084877
- PMCID: PMC1890014
- DOI: 10.1016/j.virol.2006.09.036
Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion
Abstract
HIV infects macrophages and microglia in the central nervous system (CNS), which express lower levels of CD4 than CD4+ T cells in peripheral blood. To investigate mechanisms of HIV neurotropism, full-length env genes were cloned from autopsy brain and lymphoid tissues from 4 AIDS patients with HIV-associated dementia (HAD). Characterization of 55 functional Env clones demonstrated that Envs with reduced dependence on CD4 for fusion and viral entry are more frequent in brain compared to lymphoid tissue. Envs that mediated efficient entry into macrophages were frequent in brain but were also present in lymphoid tissue. For most Envs, entry into macrophages correlated with overall fusion activity at all levels of CD4 and CCR5. gp160 nucleotide sequences were compartmentalized in brain versus lymphoid tissue within each patient. Proline at position 308 in the V3 loop of gp120 was associated with brain compartmentalization in 3 patients, but mutagenesis studies suggested that P308 alone does not contribute to reduced CD4 dependence or macrophage-tropism. These results suggest that HIV adaptation to replicate in the CNS selects for Envs with reduced CD4 dependence and increased fusion activity. Macrophage-tropic Envs are frequent in brain but are also present in lymphoid tissues of AIDS patients with HAD, and entry into macrophages in the CNS and other tissues is dependent on the ability to use low receptor levels and overall efficiency of fusion.
Figures







Similar articles
-
Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.J Virol. 2004 Jul;78(13):6915-26. doi: 10.1128/JVI.78.13.6915-6926.2004. J Virol. 2004. PMID: 15194768 Free PMC article.
-
Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.J Virol. 2001 Nov;75(21):10073-89. doi: 10.1128/JVI.75.21.10073-10089.2001. J Virol. 2001. PMID: 11581376 Free PMC article.
-
Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.J Virol. 2009 Jun;83(11):5430-41. doi: 10.1128/JVI.02648-08. Epub 2009 Mar 25. J Virol. 2009. PMID: 19321618 Free PMC article.
-
HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies.J Leukoc Biol. 2014 Jan;95(1):71-81. doi: 10.1189/jlb.0713368. Epub 2013 Oct 24. J Leukoc Biol. 2014. PMID: 24158961 Free PMC article. Review.
-
Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues.J Neuroimmune Pharmacol. 2007 Mar;2(1):32-41. doi: 10.1007/s11481-006-9042-2. Epub 2006 Nov 7. J Neuroimmune Pharmacol. 2007. PMID: 18040824 Review.
Cited by
-
The HIV-1 env protein: a coat of many colors.Curr HIV/AIDS Rep. 2012 Mar;9(1):52-63. doi: 10.1007/s11904-011-0107-3. Curr HIV/AIDS Rep. 2012. PMID: 22237899 Free PMC article. Review.
-
Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.PLoS Pathog. 2015 Mar 26;11(3):e1004720. doi: 10.1371/journal.ppat.1004720. eCollection 2015 Mar. PLoS Pathog. 2015. PMID: 25811757 Free PMC article. Clinical Trial.
-
Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.J Virol. 2014 Feb;88(4):1858-69. doi: 10.1128/JVI.02477-13. Epub 2013 Dec 4. J Virol. 2014. PMID: 24307580 Free PMC article.
-
Antiretroviral therapy and central nervous system HIV type 1 infection.J Infect Dis. 2008 May 15;197 Suppl 3(Suppl 3):S294-306. doi: 10.1086/533419. J Infect Dis. 2008. PMID: 18447615 Free PMC article. Review.
-
Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12.Retrovirology. 2009 Jul 20;6:69. doi: 10.1186/1742-4690-6-69. Retrovirology. 2009. PMID: 19619305 Free PMC article.
References
-
- An SF, Groves M, Gray F, Scaravilli F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol. 1999;58(11):1156–62. - PubMed
-
- Ancuta P, Bakri Y, Chomont N, Hocini H, Gabuzda D, Haeffner-Cavaillon N. Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains. J Immunol. 2001;166(6):4244–53. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials